Influence of Residual Tumor Volume and Radiation Dose Coverage in Outcomes for Clival Chordoma

Mark W. McDonald, Okechukwu R. Linton, Michael Moore, Jonathan Y. Ting, Aaron A. Cohen-Gadol, Mitesh V. Shah

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Purpose The purpose of this study was to evaluate factors associated with tumor control in clival chordomas. Methods and Materials A retrospective review of 39 patients treated with surgery and proton therapy for clival chordomas between 2004 and 2014 was performed. The median prescribed dose was 77.4 Gy (relative biological effectiveness [RBE]); range was 70.2-79.2 Gy (RBE). Minimum and median doses to gross tumor volume (GTV), radiation dose received by 1 cm3 of GTV (D1cm3), and the equivalent uniform dose were calculated. Receiver operating characteristics curves evaluated the predictive sensitivity and specificity for local failure of potential cutpoint values for GTV and D1cm3. Results After a median follow-up of 51 months, the 5-year estimate of local control (LC) was 69.6% (95% confidence interval [CI] 50.0%-89.2%), and overall survival (OS) was 81.4% (95% CI: 65.3%-97.5%). Tumor histology, GTV at the time of radiation, and prescribed radiation dose were significantly associated with local control on multivariate analysis, whereas D1cm3 was associated with overall survival. Compared to those patients whose conditions remained controlled, patients experiencing tumor failure had statistically significant larger GTVs and lower D1cm3, and prescribed and median doses to GTV. A subset of 21 patients with GTV of ≤20 cm3 and D1cm3 of >67 Gy (RBE) had a median follow-up of 47 months. The 5-year estimate of local control in this subset was 81.1% (95% CI: 61.7%-100%; P=.004, overall comparison by GTV ≤20 cm3 stratified by D1cm3). A D1cm3 of 74.5 Gy (RBE) had 80% sensitivity for local control and 60% specificity, whereas a GTV of 9.3 cm3 had 80% sensitivity for local control and 66.7% specificity. Conclusions Local control of clival chordomas was associated with both smaller size of residual tumor and more complete high-dose coverage of residual tumor. Multidisciplinary care should seek maximal safe surgical resection, particularly to facilitate delivery of high-dose radiation therapy in proximity to critical structures. A D1cm3 ≥74.5 Gy (RBE) represents a proposed treatment planning objective.

Original languageEnglish (US)
Pages (from-to)304-311
Number of pages8
JournalInternational Journal of Radiation Oncology Biology Physics
Volume95
Issue number1
DOIs
StatePublished - May 1 2016
Externally publishedYes

Fingerprint

Chordoma
Residual Volume
Residual Neoplasm
Tumor Burden
Relative Biological Effectiveness
tumors
Radiation
dosage
radiation
Confidence Intervals
confidence
Proton Therapy
Neoplasms
intervals
Survival
set theory
sensitivity
ROC Curve
Histology
Radiotherapy

ASJC Scopus subject areas

  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Influence of Residual Tumor Volume and Radiation Dose Coverage in Outcomes for Clival Chordoma. / McDonald, Mark W.; Linton, Okechukwu R.; Moore, Michael; Ting, Jonathan Y.; Cohen-Gadol, Aaron A.; Shah, Mitesh V.

In: International Journal of Radiation Oncology Biology Physics, Vol. 95, No. 1, 01.05.2016, p. 304-311.

Research output: Contribution to journalArticle

McDonald, Mark W. ; Linton, Okechukwu R. ; Moore, Michael ; Ting, Jonathan Y. ; Cohen-Gadol, Aaron A. ; Shah, Mitesh V. / Influence of Residual Tumor Volume and Radiation Dose Coverage in Outcomes for Clival Chordoma. In: International Journal of Radiation Oncology Biology Physics. 2016 ; Vol. 95, No. 1. pp. 304-311.
@article{100ced1497b34aff883551e666ca800d,
title = "Influence of Residual Tumor Volume and Radiation Dose Coverage in Outcomes for Clival Chordoma",
abstract = "Purpose The purpose of this study was to evaluate factors associated with tumor control in clival chordomas. Methods and Materials A retrospective review of 39 patients treated with surgery and proton therapy for clival chordomas between 2004 and 2014 was performed. The median prescribed dose was 77.4 Gy (relative biological effectiveness [RBE]); range was 70.2-79.2 Gy (RBE). Minimum and median doses to gross tumor volume (GTV), radiation dose received by 1 cm3 of GTV (D1cm3), and the equivalent uniform dose were calculated. Receiver operating characteristics curves evaluated the predictive sensitivity and specificity for local failure of potential cutpoint values for GTV and D1cm3. Results After a median follow-up of 51 months, the 5-year estimate of local control (LC) was 69.6{\%} (95{\%} confidence interval [CI] 50.0{\%}-89.2{\%}), and overall survival (OS) was 81.4{\%} (95{\%} CI: 65.3{\%}-97.5{\%}). Tumor histology, GTV at the time of radiation, and prescribed radiation dose were significantly associated with local control on multivariate analysis, whereas D1cm3 was associated with overall survival. Compared to those patients whose conditions remained controlled, patients experiencing tumor failure had statistically significant larger GTVs and lower D1cm3, and prescribed and median doses to GTV. A subset of 21 patients with GTV of ≤20 cm3 and D1cm3 of >67 Gy (RBE) had a median follow-up of 47 months. The 5-year estimate of local control in this subset was 81.1{\%} (95{\%} CI: 61.7{\%}-100{\%}; P=.004, overall comparison by GTV ≤20 cm3 stratified by D1cm3). A D1cm3 of 74.5 Gy (RBE) had 80{\%} sensitivity for local control and 60{\%} specificity, whereas a GTV of 9.3 cm3 had 80{\%} sensitivity for local control and 66.7{\%} specificity. Conclusions Local control of clival chordomas was associated with both smaller size of residual tumor and more complete high-dose coverage of residual tumor. Multidisciplinary care should seek maximal safe surgical resection, particularly to facilitate delivery of high-dose radiation therapy in proximity to critical structures. A D1cm3 ≥74.5 Gy (RBE) represents a proposed treatment planning objective.",
author = "McDonald, {Mark W.} and Linton, {Okechukwu R.} and Michael Moore and Ting, {Jonathan Y.} and Cohen-Gadol, {Aaron A.} and Shah, {Mitesh V.}",
year = "2016",
month = "5",
day = "1",
doi = "10.1016/j.ijrobp.2015.08.011",
language = "English (US)",
volume = "95",
pages = "304--311",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Influence of Residual Tumor Volume and Radiation Dose Coverage in Outcomes for Clival Chordoma

AU - McDonald, Mark W.

AU - Linton, Okechukwu R.

AU - Moore, Michael

AU - Ting, Jonathan Y.

AU - Cohen-Gadol, Aaron A.

AU - Shah, Mitesh V.

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Purpose The purpose of this study was to evaluate factors associated with tumor control in clival chordomas. Methods and Materials A retrospective review of 39 patients treated with surgery and proton therapy for clival chordomas between 2004 and 2014 was performed. The median prescribed dose was 77.4 Gy (relative biological effectiveness [RBE]); range was 70.2-79.2 Gy (RBE). Minimum and median doses to gross tumor volume (GTV), radiation dose received by 1 cm3 of GTV (D1cm3), and the equivalent uniform dose were calculated. Receiver operating characteristics curves evaluated the predictive sensitivity and specificity for local failure of potential cutpoint values for GTV and D1cm3. Results After a median follow-up of 51 months, the 5-year estimate of local control (LC) was 69.6% (95% confidence interval [CI] 50.0%-89.2%), and overall survival (OS) was 81.4% (95% CI: 65.3%-97.5%). Tumor histology, GTV at the time of radiation, and prescribed radiation dose were significantly associated with local control on multivariate analysis, whereas D1cm3 was associated with overall survival. Compared to those patients whose conditions remained controlled, patients experiencing tumor failure had statistically significant larger GTVs and lower D1cm3, and prescribed and median doses to GTV. A subset of 21 patients with GTV of ≤20 cm3 and D1cm3 of >67 Gy (RBE) had a median follow-up of 47 months. The 5-year estimate of local control in this subset was 81.1% (95% CI: 61.7%-100%; P=.004, overall comparison by GTV ≤20 cm3 stratified by D1cm3). A D1cm3 of 74.5 Gy (RBE) had 80% sensitivity for local control and 60% specificity, whereas a GTV of 9.3 cm3 had 80% sensitivity for local control and 66.7% specificity. Conclusions Local control of clival chordomas was associated with both smaller size of residual tumor and more complete high-dose coverage of residual tumor. Multidisciplinary care should seek maximal safe surgical resection, particularly to facilitate delivery of high-dose radiation therapy in proximity to critical structures. A D1cm3 ≥74.5 Gy (RBE) represents a proposed treatment planning objective.

AB - Purpose The purpose of this study was to evaluate factors associated with tumor control in clival chordomas. Methods and Materials A retrospective review of 39 patients treated with surgery and proton therapy for clival chordomas between 2004 and 2014 was performed. The median prescribed dose was 77.4 Gy (relative biological effectiveness [RBE]); range was 70.2-79.2 Gy (RBE). Minimum and median doses to gross tumor volume (GTV), radiation dose received by 1 cm3 of GTV (D1cm3), and the equivalent uniform dose were calculated. Receiver operating characteristics curves evaluated the predictive sensitivity and specificity for local failure of potential cutpoint values for GTV and D1cm3. Results After a median follow-up of 51 months, the 5-year estimate of local control (LC) was 69.6% (95% confidence interval [CI] 50.0%-89.2%), and overall survival (OS) was 81.4% (95% CI: 65.3%-97.5%). Tumor histology, GTV at the time of radiation, and prescribed radiation dose were significantly associated with local control on multivariate analysis, whereas D1cm3 was associated with overall survival. Compared to those patients whose conditions remained controlled, patients experiencing tumor failure had statistically significant larger GTVs and lower D1cm3, and prescribed and median doses to GTV. A subset of 21 patients with GTV of ≤20 cm3 and D1cm3 of >67 Gy (RBE) had a median follow-up of 47 months. The 5-year estimate of local control in this subset was 81.1% (95% CI: 61.7%-100%; P=.004, overall comparison by GTV ≤20 cm3 stratified by D1cm3). A D1cm3 of 74.5 Gy (RBE) had 80% sensitivity for local control and 60% specificity, whereas a GTV of 9.3 cm3 had 80% sensitivity for local control and 66.7% specificity. Conclusions Local control of clival chordomas was associated with both smaller size of residual tumor and more complete high-dose coverage of residual tumor. Multidisciplinary care should seek maximal safe surgical resection, particularly to facilitate delivery of high-dose radiation therapy in proximity to critical structures. A D1cm3 ≥74.5 Gy (RBE) represents a proposed treatment planning objective.

UR - http://www.scopus.com/inward/record.url?scp=84951850370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951850370&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2015.08.011

DO - 10.1016/j.ijrobp.2015.08.011

M3 - Article

C2 - 26519991

AN - SCOPUS:84951850370

VL - 95

SP - 304

EP - 311

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 1

ER -